Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Crossflo Dilution

Crossflo Dilution

posted on Aug 25, 2008 11:44AM

387,448,755 shares outstanding per 10-K as of May 31, 2008. Per today's trading, PTSC is worth on average 24 cents with a market cap of $92.99M.

If Crossflo deal goes through at approximately 24.5 cents or thereabout as it seems it will based on the last week and a day of trading, that will add approximately 30,204,081 shares to the outstanding shares, raising the number to 417,652,836.



Presumably, Crossflo will INITIALLY be a cash flow negative and/or a balance sheet negative transaction, so it's unlikely, until we find out more about them through PTSC disclosure, that there will be an immediate value adding nature to their deal. So for the point of analysis, the market cap would remain the same, and the new share base will be larger, reducing the per share value to 22.3 cents per share.



I'd assume if the pps remains at around 24 to 25 cents at closing through the end of the month, that once the deal is announced as closed, we might see a dip down to the 22 cent level or so, maybe a touch lower. But as more info comes out about Crossflo operations, and what the likely positives are, it seems that we should start to see appreciation from that information, I would think.



Any thoughts?


Aug 25, 2008 03:14PM
Share
New Message
Please login to post a reply